Moreover, patients with high expression of TRIT1 had poor prognosis in different tumor stages (especially T2, T1&T2, T3&T2), presence or absence of lymph node metastasis (N0&N1), FA&HA, and HC&Hep subgroups (Figure 6). This evidence concerns the gene TRIT1 and neoplasm.